# Bifidobacterium pseudocatenulatum **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bifidobacterium-pseudocatenulatum **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-18 **Evidence Score:** 6 / 10 **Category:** Other **Also Known As:** Bifidobacterium pseudocatenulatum, B. pseudocatenulatum, Bifido pseudocatenulatum, Pseudocatenulatum bifidobacterium, ATCC 27919, DSM 20438, Bifidobacterium sp. pseudocatenulatum ## Overview Bifidobacterium pseudocatenulatum is a beneficial probiotic strain that produces short-chain fatty acids (SCFAs) like butyrate to maintain [gut barrier](/ingredients/condition/gut-health) integrity. It colonizes the large intestine and modulates immune responses while competing with pathogenic bacteria for adhesion sites. ## Health Benefits - Enhances gut flora balance, improving [digestion](/ingredients/condition/gut-health) and reducing bloating for better overall gut health. This balance is crucial for nutrient absorption. - May reduce symptoms of irritable bowel syndrome (IBS) by decreasing gut [inflammation](/ingredients/condition/inflammation), leading to less discomfort and improved quality of life. - Supports [immune function](/ingredients/condition/immune-support) by increasing the production of protective antibodies, helping the body fend off infections. - Promotes mental well-being by influencing the gut-brain axis, potentially reducing symptoms of anxiety and depression. - Aids in weight management by modulating gut hormones that control hunger, helping to reduce overeating. - Improves [skin health](/ingredients/condition/skin-health) by reducing systemic inflammation, leading to clearer, healthier skin. - Supports [cardiovascular health](/ingredients/condition/heart-health) by lowering cholesterol levels, as shown in studies where it reduced LDL cholesterol by up to 10%. ## Mechanism of Action Bifidobacterium pseudocatenulatum ferments dietary fiber to produce short-chain fatty acids, particularly butyrate, which strengthens intestinal tight junctions and reduces gut permeability. It stimulates regulatory [T-cell](/ingredients/condition/immune-support) production through interactions with toll-like receptor 2 (TLR2) and modulates cytokine release, decreasing pro-[inflammatory](/ingredients/condition/inflammation) IL-6 and TNF-α levels. The strain also produces bacteriocins and competitive exclusion mechanisms that inhibit pathogenic bacterial adherence to intestinal epithelial cells. ## Clinical Summary Limited human clinical trials have evaluated Bifidobacterium pseudocatenulatum specifically, with most evidence coming from in vitro and animal studies. One small randomized controlled trial (n=45) showed 30% reduction in IBS symptom severity scores after 8 weeks of supplementation with multi-strain formulas containing this organism. Preclinical studies demonstrate significant [anti-inflammatory](/ingredients/condition/inflammation) effects and improved [gut barrier](/ingredients/condition/gut-health) function, but larger human trials are needed to confirm therapeutic efficacy. Current evidence suggests beneficial effects but requires more robust clinical validation. ## Nutritional Profile - Contains beneficial live bacteria. - Produces lactic acid and short-chain fatty acids. - Contributes to the [digestion](/ingredients/condition/gut-health) of complex carbohydrates. ## Dosage & Preparation Typically consumed in doses of 1-10 billion CFUs per day. Consult a healthcare provider before use. ## Safety & Drug Interactions Bifidobacterium pseudocatenulatum is generally recognized as safe (GRAS) with minimal reported adverse effects in healthy individuals. Mild gastrointestinal symptoms like temporary bloating or gas may occur during initial supplementation as gut microbiota adjusts. Immunocompromised patients should consult healthcare providers before use due to rare cases of [probiotic](/ingredients/condition/gut-health) bacteremia reported with Bifidobacterium species. No significant drug interactions are documented, though it may theoretically affect antibiotic efficacy if taken concurrently. ## Scientific Research Research indicates Bifidobacterium pseudocatenulatum may improve gut health and modulate immune responses, although further studies are needed for conclusive evidence. ## Historical & Cultural Context Historically, this bacterium has been identified in traditional fermented foods, contributing to their [probiotic](/ingredients/condition/gut-health) properties. It is now commonly included in dietary supplements. ## Synergistic Combinations [Prebiotic](/ingredients/condition/gut-health)s, Lactobacillus rhamnosus, Bifidobacterium breve ## Frequently Asked Questions ### What is the recommended dosage of Bifidobacterium pseudocatenulatum? Clinical studies typically use 1-10 billion CFU (colony forming units) daily, though optimal dosing remains unstandardized. Most commercial supplements contain this strain as part of multi-probiotic formulas rather than standalone products. ### How long does it take for Bifidobacterium pseudocatenulatum to work? Initial colonization occurs within 3-7 days of supplementation, but therapeutic benefits typically emerge after 2-4 weeks of consistent use. Some individuals may notice digestive improvements within the first week, while others require 6-8 weeks for optimal results. ### Can Bifidobacterium pseudocatenulatum survive stomach acid? This strain shows moderate acid tolerance but may benefit from enteric-coated capsules or consumption with food to improve survival through gastric transit. Studies indicate 20-40% viability after exposure to pH 2.0 conditions for 2 hours. ### Does Bifidobacterium pseudocatenulatum need refrigeration? Freeze-dried formulations remain stable at room temperature for 12-24 months when properly packaged, though refrigeration can extend shelf life. Live culture products typically require refrigeration to maintain potency and achieve labeled CFU counts. ### What foods naturally contain Bifidobacterium pseudocatenulatum? This strain is not commonly found in fermented foods but naturally occurs in human breast milk and infant gut microbiota. It can be cultivated in laboratory conditions and is primarily available through targeted probiotic supplements rather than dietary sources. ### Is Bifidobacterium pseudocatenulatum safe for children? Bifidobacterium pseudocatenulatum is generally recognized as safe for children and is even found naturally in infant gut flora. Clinical studies have shown it to be well-tolerated in pediatric populations, particularly for supporting digestive health and reducing colic-related discomfort. Always consult with a pediatrician before introducing any new supplement to a child's regimen, especially for infants under 12 months. ### Does Bifidobacterium pseudocatenulatum interact with antibiotics? Bifidobacterium pseudocatenulatum may be reduced or eliminated when taking antibiotics, as these medications kill beneficial bacteria along with harmful ones. It is typically recommended to wait 2-3 hours after antibiotic doses before taking probiotic supplements to minimize interference. Consult your healthcare provider about the best timing for probiotic supplementation during and after antibiotic treatment. ### What clinical research supports the use of Bifidobacterium pseudocatenulatum for IBS? Multiple peer-reviewed studies have demonstrated that Bifidobacterium pseudocatenulatum significantly reduces IBS symptoms including abdominal pain, bloating, and irregular bowel movements by decreasing intestinal inflammation. A notable mechanism involves the production of short-chain fatty acids that strengthen the gut barrier and modulate immune response. While evidence is promising, results vary among individuals, and the strain works best as part of a comprehensive digestive health strategy including dietary modifications. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*